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Pharmaceutical formulationsThis paper describes two simple and novel analytical methods by using spectrophotometric technique for
the determination of caroverine a spasmolytic drug in pharmaceutical formulations. The ﬁrst (A) is a
direct method in which analysis of the pure drug was carried out at its kmax 304 nm in ethanol solvent.
The method was linear from 0.5 to 18 lg/ml with correlation coefﬁcient of 0.999 and molar absorptivity
of 5.55  104 L mole1 cm1. Limit of detection and limit of quantiﬁcation were 0.44 and 1.47 lg/ml.
While the second method (B) is based on the charge transfer reaction between caroverine as n-electron
donor and 7,7,8,8-tetracyanoquinodimethane (TCNQ) as pi-acceptor resulting in highly colored stable
complex, which showed maximum absorption band at wavelength of 525 nm. The thermodynamic
parameters were calculated as association constant KCT of 7.53  104 mol1 and Gibbs free energy DG
of 6.72 kJ mol1. Different variables affecting the charge transfer reaction were carefully studied and
optimized. At the optimum reaction conditions, Beer’s law was obeyed in a concentration range
of 1–35 lg ml1 with molar absorptivity of 1.17  104 L mole1 cm1 and correlation coefﬁcient of
0.9999. The proposed methods were validated according to ICH guidelines.
 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
A counterfeit medication or a counterfeit drug is a medication
or pharmaceutical product which is produced and sold with the
intent to deceptively represent its origin, authenticity or effective-
ness. A counterfeit drug may contain inappropriate quantities of
active ingredients, or none, may be improperly processed within
the body (e.g., absorption by the body), may contain ingredients
that are not on the label [1]. The concern about the quality of drugs
marketed increases every year not only in commercial terms, but
also legal and ethical aspects, since the health of patients depends
on the quality and effectiveness of these drugs. For this purpose
different regulatory authorities around the world are demanding
speciﬁc and validated analytical methods for the registration of
new drugs to ensure their quality. So there is a great interest in
developing rapid and efﬁcient analytical methods that provide pre-
cise and accurate parameters for the quantitative analysis of drugs
in pharmaceutical raw and dosage forms.
Caroverine 1-(2-diethylaminoethyl)-3-(p-methoxybenzyl)-1,2-
dihydro-2-quinoxalin-2-on-hydrochloride is chemically derived
from isoquinoline, the basic structure of papaverin. It is clinicallyavailable in some countries as a spasmolytic drug based on its
unspeciﬁc Ca2+ channel blocking activity for more than 40 years.
Caroverine is a drug used as a spasmolytic and otoneuroprotective
(inner ear protective) agent in some countries. It acts as an N-type
calcium channel blocker, competitive AMPA (a-amino-3-hydroxy-
5-methyl-4-isoxazolepropionic acid receptor) receptor antagonist,
and non-competitive NMDA (N-methyl-D-aspartate receptor)
receptor antagonist [2]. It also has potent antioxidant effects [3].
In Pakistan, caroverine is marketed as Sparina tablets 20 mg
(Biopharma, Multan, Pakistan) for oral smooth muscle spasms.
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gle analytical method is available for the quantitative determina-
tion of caroverine in pharmaceutical raw and dosage forms. The
assay of caroverine in pure and dosage forms, as far as we know,
is not ofﬁcial in any pharmacopoeia, and therefore, requires much
more investigation.
The molecular interactions between electron donors and accep-
tors are generally associated with the formation of intensely col-
ored charge transfer complexes, which absorb radiation in the
visible region [4]. A variety of electron donating compounds have
been reported to yield charge-transfer complexes with various p-
acceptors [5–9].
The objective of this study was to develop a simple and vali-
dated spectrophotometric method for routine analysis of carover-
ine tablets in pharmaceutical laboratories.2. Experimental
2.1. Apparatus
A Hitachi U 1100, UV/Vis spectrophotometer (Japan) with silica
glass cell of 1 cm thickness was used. Ofﬁcially calibrated Pyrex
glass-ware was used throughout this study.2.2. Reagents and standards
Caroverine pure sample and Sparina tablets were supplied by
Bio Fine Pharmaceuticals (Pvt.) Ltd. Multan, Pakistan as gift sam-
ples. All reagents and solvents used were of Analytical Reagent
Grade. While 7,7,8,8-tetracyanoquinodimethane (TCNQ) (Fluka,
Switzerland) 1.0 mg ml1 solution was prepared in acetonitrile
(Merck, Germany). The standard drug solution of 1 mg ml1 was
prepared by dissolving 100 mg of pure drug sample in 100 ml
DMSO (Sigma–Aldrich, Germany) solvent. 0.001 M solution of
caroverine and TCNQ was prepared by dissolving 0.402 mg of pure
drug in 100 ml DMSO and 0.204 mg TCNQ in acetonitrile solvent
respectively.2.3. Recommended procedures
2.3.1. Method A
Different aliquots of standard solution of caroverine (0.5–
18 lg ml1) were prepared in DMSO. Absorbance of these solutions
was noted at 304 nm against a reagent blank.2.3.2. Method B
A suitable amount of the drug solution, containing 1–
35 lg ml1 caroverine was pipetted into a series of 10 ml volumet-
ric ﬂask. Then 1 ml of TCNQ solution was added to each ﬂask. The
solution was kept in thermostat at 40 C of water bath for 5 min.
After cooling at room temperature the volume was made up to
mark with DMSO and the absorbance of the colored complex was
measured at 525 nm against a reagent blank.2.4. Analysis of pharmaceutical formulations
2.4.1. Method A
20 tablets were weighed accurately then were pulverized care-
fully with mortar and pistol. An amount of the powdered equiva-
lent to 100 mg of the pure drug was weighed accurately and
transferred into a 100 ml calibrated ﬂask. Dissolve the contents
in 50 ml DMSO solvent by sonicated then made the volume up to
the mark with same solvent. Filter the solution through
Whatman ﬁlter paper 42. Then take 10 ml from this ﬁltrate anddilute up to 100 ml with DMSO and take the absorbance of this
10 lg ml1 solution at 260 nm against reagent blank.
2.4.2. Method B
20 tablets were weighed accurately then were pulverized care-
fully with mortar and pistol. An amount of the powdered equiva-
lent to 100 mg of the pure drug was weighed accurately and
transferred into a 100 ml calibrated ﬂask, dissolved in DMSO,
swirled and sonicated for 3 min, the solution was diluted to vol-
ume with ethanol. Then take 1 ml from this solution in 100 ml vol-
umetric ﬂask and treat as described in recommended procedure
(method A). After ﬁltration from Whatman ﬁlter paper 42 take
absorbance at 525 nm against reagent blank.
2.5. Molar ratio of reactants in complex
The Job’s method of continuous variation was employed [10].
An equal molarity solution of the caroverine and TCNQ were pre-
pared. A series of 10 ml portions of the master solutions of the drug
with TCNQ reagent were made up comprising different comple-
mentary proportions (0:10, 1:9, . . .,9:1, 10:0) in 10 ml volumetric
ﬂasks. The reaction was allowed to proceed as the described in pro-
posed method. The absorbance of the solutions was measured at
525 nm against the reagent blank.
3. Results and discussion
The method A is based on the simple scanning of caroverine in
DMSO solvent and its determination in the presence of various
excipients. While the method B is based on the charge-transfer
(CT) reaction. The CT reaction has been widely studied recently.
Many drugs are easy to be determined by spectrophotometry
based on color CT complexes formed with electron acceptors. The
charge-transfer (CT) reactions have been widely studied recently.
Many drugs are easy to be determined by spectrophotometry
based on color charge-transfer (CT) complexes formed with elec-
tron acceptors [11–14]. The charge-transfer (CT) complexes are
formed between electron donors, having sufﬁciently low ionization
potential, and acceptors, having sufﬁciently high electron afﬁnity.
3.1. Absorption spectra
For method A 10 lg/ml solution of caroverine in DMSO was
scanned from 200 to 400 nm against a reagent blank and maxi-
mum absorbance was determined at 304 nm as shown in
Fig. 1(a). While in method B caroverine reacts with TCNQ solution
in DMSO medium and produce the highly colored complex that
show maximum absorption at 525 nm as shown in Fig. 1(b).
3.2. Reaction mechanism
TCNQ has been used for quantitative determination of pharma-
ceutical drugs in dosage forms by charge-transfer complex forma-
tion. Interaction with TCNQ in acetonitrile solution was found to
yield a deep color causing characteristic longer wavelength absorp-
tion band. The predominant chromogen with TCNQ is blue colored
radical anion, which probably resulted through the dissociation of
an original donor–acceptor complex with the drug. This complex is
formed by the lone pair of electron donated by the caroverine base
as n donor and the charge transfer reagent as an electron acceptor,
where a partial ionic bond (D+ A+) is assumed to be formed.
00.3
0.6
0.9
1.2
0.1 0.3 0.5 0.7 0.9
A
bs
or
ba
nc
e
Mole fraction of drug (Vd/Vd +Vr)
Fig. 2. Stoichiometric ratio of the charge transfer complex (caroverine–TCNQ).
Fig. 1. Absorption maximum of caroverine in DMSO solvent (a) and caroverine–TCNQ complex (b).
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3.3. Stoichiometry of the complex
The application of Job’s method of continuous variation shod
that 1:1 molar ratio is found in complex between caroverine and
TCNQ reagent as shown in Fig. 2.
3.4. Interference study
To study the potential interference problems from the com-
monly used excipients and other additives such as microcrystalline
cellulose, lactose, primojel and magnesium stearate, recoveryScheme 1. Proposed reaction pathways between caroverine and TCNQ.studies were carried out. Under the experimental conditions
employed, to a known amount of drug (caroverine 10 lm/ml),
excipients in different concentrations were added and analyzed.
Results of the recovery analysis are presented in Table 1.
Excipients up to the concentrations shown in the Table 1 do not
interfere with the assay. In addition recoveries in most cases were
around 100% and the lower values of the RSD indicate the good
precision of the method.3.5. Choice of solvent
3.5.1. Method A
Different solvents including methanol, ethanol, acetonitrile,
acetone, dimethyl formamide (DMF) and dimethyl sulﬁde
(DMSO) were used in order to ﬁnd most the suitable solvent.
10 lg/ml solution of caroverine in different solvents was scanned
from 200 to 400 nm for maximum absorbance as shown in Fig. 3.
Experimental results in Table 2 indicate that DMSO is found to
be the most suitable diluting solvent for caroverine due to its sol-
ubility and molar absorptivity.Table 1
Percent recovery of the caroverine in the presence of possible excipients used in
tablet formulation.
Excipients Amount
taken
(lm/ml)
Method A
% Recovery
± RSD (n = 5)
Method B
% Recovery
± RSD (n = 5)
Microcrystalline cellulose 400 99.29 ± 0.37 100.23 ± 0.21
Magnesium stearate 200 99.76 ± 0.28 98.97 ± 0.79
Titanium dioxide 150 100.21 ± 0.30 99.87 ± 0.67
Lactose 200 99.78 ± 0.31 100.56 ± 0.86
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Fig. 3. Absorption spectra of caroverine in various solvents.
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Fig. 4. Absorption spectra of reaction mixture of caroverine with TCNQ.
Table 3
Effect of solvent on the interaction of caroverine with TCNQ.
Solvent Mol. Wt.
(g/mole)
Dielectric
constant
Absorbance kmax Molar
absorptivity
(L mol1 cm1) (e)
Methanol 32.04 32.7 0.358 480 1.14  103
Ethanol 46.06 24.6 1.19 470 5.4  103
Acetonitrile 41.05 37.5 0.145 510 5.95  102
DMSO 78.13 46.7 1.54 525 1.2  104
Acetone 58.08 20.7 0.859 460 4.9  103
DMF 73.09 36.7 1.13 420 8.2  103
Table 4
Optimization of experimental conditions for the assay of caroverine based on CT
complex formation with TCNQ.
Condition Studied range Optimum conditions
Solvent Various DMSO
Reaction time (min) 0–30 10
Temperature 25–60 40
TCQN Conc. (ml) 0.5–5.0 1.0
kmax (nm) 400–800 525
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The interaction of TCNQ with caroverine was carried out indif-
ferent solvents of varying dielectric constants and their absorption
spectra were recorded as shown in Fig. 4. The maximum absorp-
tion peaks (kmax) and molar absorptivity (e) were determined in
each solvent as shown in Table 3. The interaction in DMSO solvent
with produced more intense higher e values than those in solvents
because it affords an excellent solvating power for TCNQ reagent
and gives the highest absorbance value. Especially DMSO being a
polar solvent, facilitates the complete transfer of charge from
donor to acceptor with the formation of radical anion as the pre-
dominant chromogen. Although the formation of TCNQ radical
was possible in methanol and acetonitrile but the color intensity
was lower as compared to DMSO.
3.6. Association constants and standard free energy changes
The association constant was determined for the interaction of
caroverine–TCNQ complex using Benesi Hildebrand equation [15].
Ca
A
¼ 1
e
þ 1
KC e
1
Cb
where Ca and Cb are the concentrations of the acceptor and donor
respectively, A is the absorbance of the complex, e is the molar
absorptivity of the complex and KC is the association constant of
the complex. The standard free energy changes of complexation
(DG) were calculated from the association constants by the follow-
ing equation [16].
DG ¼ 2:303RT log KC
where DG is the free energy change of the complex (kJ mol1), R
the gas constant (0.001987 K cal mol1 deg1), T the temperature
in Kelvin (273 + C) and KC is the association constant of drug–ac-
ceptor complex (l mol1).
3.7. Optimization of the assay conditions for method B
The conditions for the reaction of caroverine with TCNQ were
optimized by altering each reaction variable in a turn while keep-
ing the others constant. The studied conditions were concentrationTable 2
Effect of various solvents on calculation of absorbance and molar absorptivity.
Solvent Mol. Wt. (g/mole) Dielectric constant Absorbanc
Methanol 32.04 32.7 1.08
Ethanol 46.06 24.6 0.974
Acetonitrile 41.05 37.5 0.102
DMSO 78.13 46.7 1.97
Acetone 58.08 20.7 0.106
DMF 73.09 36.7 1.04of TCNQ reagent, reaction time, and temperature. The studied
range of these conditions and the optimum value that was selected
for the assay development are given in Table 4.
3.7.1. Effect of color producing reagent
7,7,8,8-Tetracyanoquinodimethane (TCNQ) was used as color
producing reagent. It was found that 1 ml of l mg/ml solution of
7,7,8,8-tetracyanoquinodimethane (TCNQ) gave maximum color
(Fig. 5), above and below this concentration the color intensity
diminished and color becomes unstable. So 1 ml of l mg/ml solu-
tion of TCNQ was considered the optimum value for maximum
color development.
3.7.2. Effect of temperature and heating time
The effect of temperature is shown in Fig. 6. The color starts
developing at 30 C and reaches its maximum intensity at 40 C.
As the temperature increases the complex starts dissociating, duee Solubility kmax Molar absorptivity (L mol1 cm1) (e)
Partially 280 3.4  103
Partially 320 4.4  103
Partially 300 4.1  102
Completely 304 1.5  104
Partially 300 6.5  102
Partially 320 7.6  103
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Fig. 5. Effect of color producing reagent.
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Fig. 7. Effect of heating on color development.
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Fig. 8. Beer’s law veriﬁcation range for method A (a) and method B (b).
Table 5
Spectral and Benesi–Hildebrand data for the reaction of caroverine–TCNQ complex.
Parameters Values for
method A
Values for
method B
kmax (nm) 304 525
Beer’s law limits (lg/ml) 0.5–18 1–35
Molar absorptivity (L mole1 cm1) 5.55  104 1.17  104
Detection limit (lg/ml) 0.44 2.12
Quantiﬁcation limit (lg/ml) 1.47 7.00
Sandell sensitivity (lg cm2) 6.58  103 3.11  102
Slope 0.152 0.032
Intercept 0.0027 0.001
Correlation coefﬁcient 0.999 0.9995
Association constant (KC) – 7.53  104
Standard free energy change (DG) – 6.72
Table 6
Accuracy and precision data from the proposed methods.
Drug conc. (lg/ml) % Recovery (Method A) % Recovery (Method B)
Intraday Interday Intraday Interday
2 99.98 100.67 100.67 98.78
4 100.05 99.45 99.56 99.14
6 99.56 98.56 99.67 99.73
8 99.15 99.76 99.25 99.49
10 100.24 99.13 100.78 100.16
Mean 99.80 99.51 99.99 99.46
STD 0.4383 0.7012 0.6931 0.5312
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on color intensity is shown in Fig. 7. It was found that heating
for 10 min at 40 C gave maximum color and above and below
these temperature and time the color intensity decreased and color
becomes unstable.3.8. Validation of the proposed methods
3.8.1. Linearity and sensitivity
Calibration curve for the analysis of caroverine by the proposed
methods A and B were constructed and it was found that Beer’s law
was linear up to 18 and 35 lg/ml, respectively as shown in Fig. 8.
The limits of detection (LOD) and quantiﬁcation (LOQ) were deter-
mined [17] and found to be 0.44 lg/ml and 1.47 for method A and
2.12 and 7.00 for method B respectively. The quantitative parame-
ters of the proposed methods are given in Table 5.3.8.2. Accuracy and precision
The accuracy of the proposed methods was determined from
the recovery results of spiked placebo samples. Stock solutions of
drugs in different concentrations 2, 4, 6, 8 and 10 lg/ml were pre-
pared and their % recovery was calculated. High recovery indicated
that the method has a high degree of accuracy for the determina-
tion of caroverine at various concentration levels. However, preci-
sion of the proposed methods were determined by repeatability
(intra-day precision) and intermediate precision (intra-day preci-
sion). It is expressed as relative standard deviation (RSD). The
absorbance of every sample was measured ﬁve times. Both intra-
and inter-day RSD values were in the range of 0.112–2.77% con-
ﬁrming good precision (Table 4).
3.8.3. Limit of detection (LOD) and quantiﬁcation (LOQ)
Same spectrophotometric reaction is carried out without active
ingredients (blank) as 5 replicate and measured the absorbances at
the same wavelength, then the mean of these absorbance is found
‘‘b’’. Value of ‘‘b + 3SD’’ (SD = standard deviation of 5 replicates) is
calculated as absorbance value ‘‘p’’.
Absorbance ðPÞ ¼mean of blankþ 3SD
LOD is calculated by comparison of absorbance (P) with absor-
bance of known concentration.
However, limit of quantiﬁcation (LOQ) can be simply calculated
by multiplying the limit of detection with Section 3.3 (see Table 6).4. Application
The currently proposed methods were applied for the determi-
nation of the caroverine in commercial preparations. Measurement
was taken in three replicates. Moreover, to check the validity of the
proposed methods, the standard addition method was applied by
adding pure caroverine to the previously analyzed tablets. The
Table 7
Applications of proposed methods to determine of caroverine in tablet formulations.
Tablets (API) Label claim Pure drug added (mg) Method (A) Method (B)
Amount recovered % Recovery % RSD Amount recovered % Recovery % RSD
Sparina tab 20 5 24.87 99.48 0.22 24.76 99.04 0.11
(caroverine) 20 10 29.33 97.77 0.31 29.45 98.17 0.26
20 15 34.71 99.17 0.28 34.61 98.89 0.53
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tion obtained from the spiked mixtures with those of the pure
drug. The results of analysis of commercial dosage forms and the
recovery study (standard addition method) of the cited drug are
presented in Table 7.5. Conclusions
The proposed spectrophotometric methods are novel because
none of the analytical method is available in the literature for the
quantitative determination of caroverine in pharmaceutical raw
and dosage forms. The methods are rapid, simple, precise and accu-
rate. The proposed procedures are free from tedious steps like
extraction or heating and involve the least number of experimental
variables, which is reﬂected in high precision. Additional advan-
tages of these methods are their speciﬁcity. Furthermore, all the
analytical reagents are inexpensive, have excellent shelf life, and
are easily available in any analytical laboratory. The proposed
method can be applied in quality control laboratories for the rou-
tine analysis of the caroverine in rawmaterials and pharmaceutical
formulations.Conﬂict of interest
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